Skip to main content

Table 1 Patient characteristics

From: Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

 

Retrospective cohort

Prospective cohort

Number of subjects

38

38

Mean age (years)

62 ± 14

58 ± 12

Sex

24 males, 14 females

23 males, 15 females

Number of treatment cycle, mean

3.26 ± 2.00

4.26 ± 2.44

Mean activity (GBq)

23.91 ± 14.67 177Lu-DOTATATE

31.68 ± 19.21 177Lu-DOTATOC

Primary tumor

  

Pancreatic NET

9

10

Small bowel NET

5

4

Ileum NET

4

6

Cerebral tumor

4

2

NET of unknown origin

4

2

Gastric NET

2

1

MTC

2

2

Caecum NET

2

2

Rectal NET

1

2

Liver NET

1

2

Thymus NET

1

1

Paraganglioma

1

1

Lung NET

1

3

Hemangioendothelioma

1

 
  1. Main baseline features of the patients enrolled in the study.